HYPOPHARYNGEAL CANCER
Clinical trials for HYPOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for HYPOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Matched conditions: HYPOPHARYNGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
AI tool aims to spot head and neck cancer risk early
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to create a risk prediction model for head and neck cancers, including cancers of the throat and voice box. Researchers will collect data from 3000 participants, including their medical history, lifestyle habits, and laryngoscopy images…
Matched conditions: HYPOPHARYNGEAL CANCER
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC